If you're looking for a play in the medical device sector, there's
a good case to make for LED Medical Diagnostics ("LEDMD")
(TSX.V:LMD) (OTCQX:LEDIF) (FSE:LME).
LEDMD operates in the dental imaging market, which consists of
devices and software used in diagnosing and treating dental
diseases and conditions. The offerings within this market include
items such as digital radiology and optical imaging devices, Cone
Beam CT scanners and CAD/CAM systems. The global market for these
goods was valued at $4.5 billion in 2011 and is expected to grow at
a CAGR of 5.8% from 2011 to 2016.
LEDMD's first product was the market-dominating VELscope® Vx
Enhanced Oral Assessment System, an innovative application of
tissue fluorescence technology to aid in the detection of oral
mucosal disease, including cancer and pre-cancer. The VELscope,
backed by an increasing number of clinical studies, is approved by
the FDA, Health Canada and European regulators. According to the
Company, more than 25-million VELscope Vx examinations have been
performed by over 12,000 dental practitioners in 23 countries.
The current story for investors, however, is LEDMD's new
executive management, its experience and past success, as well as
its aggressive strategy for the company's growth.
New Management
Dr. David Gane is LEDMD's recently appointed CEO. A dentist and
imaging executive, Gane served as VP of U.S.-based Carestream
Dental (a division of Carestream Health), an imaging and IT company
with $500M in annual revenues, 1,200 employees, and products in 90%
of the dental practices worldwide. Gane is also the founder of
Orbit Imaging Inc., a company that owns and operates craniofacial
imaging centers in Western Canada.
Dr. Gane came on board in October, 2013, when founder and
VELscope Vx inventor Peter Whitehead decided to step back from his
executive role to follow his passion as a medical device inventor.
Whitehead continues to work for the company as the head of future
product development.
Gane's first appointment was Lamar Roberts, now President of the
company's wholly-owned operating company, LED Dental. Roberts was
previously VP, Sales and Marketing at Carestream Dental and has
held senior executive positions with other leaders in the dental
industry, such as 360imaging and PracticeWorks.
Both Gane and Roberts are seasoned professionals, with
high-level contacts and a deep knowledge of the industry. Their
efforts have already increased the number of North American
distribution companies handling VELscope from one to nine, creating
a significant network of sales channels across the continent.
LEDMD has also opened a new specialized digital imaging division
– LED Imaging – and hired Dr. Jeffrey Brooks, now VP of Imaging.
Dr. Brooks is a board certified Oral and Maxillofacial Surgeon with
20 years of private practice experience. He maintains his position
as Associate Professor and 3D Imaging Director in the Department of
Oral and Maxillofacial Surgery at University of Tennessee at
Memphis. Gane worked with Brooks at Carestream, where he was VP of
Clinical Affairs.
New Products
In April, 2014, LEDMD announced a partnership with Ray Co.,
Ltd., a subsidiary of Samsung, to sell, install and provide support
for the RAYSCAN α – Expert, an imaging system that uses 3D cone
beam computed tomography (CBCT). CBCT is a compact, faster and
safer version of regular CT technology, which can provide clear
images and cross sections of high contrast structures of the teeth
face and jaws.
Dentists like their toys, and believe us when we tell you that
this toy is a big one. It allows for remote controlled interaction
with patients while performing the imaging procedure, automatically
sharpens the image, and has a system to reduce inaccuracies caused
by patient movement or poor positioning. In addition, the RAYSCAN α
– Expert features a highly refined, ergonomic design and has
already won two international design awards. With a sticker price
of $100K, it's a potential generator of big revenues. The U.S.
market alone for CBCT scanners exceeded $208M in 2012. Small to
medium field-of-view scanners like the RAYSCAN α – Expert comprised
~83% of that.
In April, 2014, LEDMD also announced its exclusive imaging
software, which enables practitioners to capture, manipulate, save,
store and share clinical images quickly and easily. The software
integrates seamlessly with RAYSCAN α – Expert systems.
In May, 2014, LEDMD introduced a new digital radiography
intraoral sensor, the LED IS100. The LED IS100 is a replacement for
traditional dental film. It captures intraoral images of the teeth
and supporting bone structures, and boasts features such as
high-definition image resolution, direct USB plug-in, and
open-architecture workflow. The company also introduced two
models of high resolution intraoral cameras, the LED IC100 and the
LED IC200. These cameras are lightweight, ergonomic and feature
LED-based illumination for clear, highly detailed images.
According to Dr. Gane, the company's aggressive product
expansion plans will also include an optical impression system for
imaging implants and crowns. The global dental CAD/CAM market is
estimated at $540M, while the low penetration of CAD/CAM technology
into the dental office setting leaves significant room for growth,
and the potential for substantial revenue gains.
Analysis
Where could this all go? The world's largest manufacturer of
dental technology, including oral imaging systems is Europe's
Sirona Dental Systems. Trading at US$80, the Company has a market
cap of $4.65 billion, and its share price has quadrupled since
January 2010.
In a June 2, 2014, Zack's Small Cap Research Report, Brian
Marckx, CFA, stated regarding LED:
"...2014 will not only provide improved financial performance
but also further progress with executing on the turnaround
strategy. This likely includes further broadening of their
distribution and commercial footprint for VELscope. Over the
mid-term we also expect LEDMD will be actively looking for
additional complementary products to add to its portfolio to
supplement revenue of their core VELscope product which will also
provide the added benefit of a diversified revenue source.
We are maintaining our Outperform rating and
DCF-generated price target of $2.00/share."
LEDMD currently has a share price of $0.37 and a market cap of
$27.5M. Given the growth that has transpired over the last 9 months
under Dr. Gane, investors would be wise to give the Company a good
look. While obviously a competitive space, the metrics and
demographics favor the current administration's aggressive and
experienced approach.
Legal Disclaimer/Disclosure: A fee has been paid for the
production and distribution of this Report. This document is not
and should not be construed as an offer to sell or the solicitation
of an offer to purchase or subscribe for any investment. No
information in this article should be construed as individualized
investment advice. A licensed financial advisor should be consulted
prior to making any investment decision. Financial Press makes no
guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. Expressions of
opinion are those of the authors only and are subject to change
without notice. Financial Press assumes no warranty, liability or
guarantee for the current relevance, correctness or completeness of
any information provided within this article and will not be held
liable for the consequence of reliance upon any opinion or
statement contained herein or any omission. Furthermore, we assume
no liability for any direct or indirect loss or damage or, in
particular, for lost profit, which you may incur as a result of the
use and existence of the information, provided within this
article.
Also, please note that republishing of this article in its
entirety is permitted as long as attribution and a back link to
FinancialPress.com are provided. Thank you.
CONTACT: LED Medical Diagnostics Inc.
235-5589 Byrne Road
Burnaby British Columbia V5J 3J1
Canada
Toll-free: 888.541.4614
Office Telephone: 604.434.4614
Fax: 604.434.4612
Email: info@ledmd.com
LED Medical Diagnostics (TSXV:LMD)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
LED Medical Diagnostics (TSXV:LMD)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024